Noviello, M <br/><br/>
Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall.  [electronic resource] 

 -  Bone marrow transplantation  Sep 2015 
 - 1262-4 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2015.132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Allografts<br/>Biomarkers--blood<br/>Cytomegalovirus--immunology<br/>Cytomegalovirus Infections--blood<br/>Female<br/>HLA Antigens<br/>Hematologic Neoplasms--blood<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Middle Aged<br/>Recovery of Function--immunology